The study goals were to examine whether cochlear implantation increases the risk of meningitis in the absence of other risk factors and to understand the pathogenesis of pneumococcal meningitis post cochlear implantation. STUDY DESIGN AND SETTING: Four weeks following surgery, 54 rats (18 of which received a cochleostomy alone, 18 of which received a cochleostomy and acute cochlear implantation using standard surgical techniques, and 18 of which received a cochlear implant) were infected with Streptococcus pneumoniae via three different routes of bacterial inoculation (middle ear, inner ear, and intraperitoneal) to represent all potential routes of bacterial infection from the upper respiratory tract to the meninges.
T he use of cochlear implants in patients with a severeprofound hearing impairment has been considered to be very safe. Although meningitis is a potential central nervous system (CNS) complication post-cochlear implantation, it was considered to be very rare. 1 During 2002, however, a sudden increase in reported cases, both in Europe and in North America, sparked international concern about the possible association between meningitis and cochlear implantation. 2 In the reported cases of meningitis, Streptococcus pneumoniae is the most common organism isolated. [2] [3] [4] The incidence of pneumococcal meningitis in cochlear implant recipients was found to be greater than that of an agematched cohort in the general population. 3 However, it is unclear if cochlear implants increase the risk of postimplant pneumococcal meningitis, as many of the reported cases also have preexisting risk factors for meningitis. Risk factors identified from the clinical records of patients with cochlear implants included an implant with a positioner, inner-ear malformations with and without cerebrospinal fluid (CSF) leak, the presence of a CSF leak after cochlear implantation, a history of ventriculoperitoneal shunt placement, and a history of otitis media. 3, 4 Many cochlear implant recipients also had previous episodes of meningitis prior to their implantation. In order to determine if a cochlear implant independently increases the risk of meningitis following a subsequent pneumococcal infection, it is important to eliminate these other confounding factors when conducting an experimental study. This is best achieved in a controlled laboratory environment where the confounding factors can be easily eliminated.
A pneumococcal meningitis model in healthy implanted rats was established previously. 5 The bacteria can reach the meninges from the upper respiratory mucosa in implanted rats, either via hematogenous routes or directly via the middle and inner ear. It has been shown that in healthy nonimplanted rats, a threshold of bacteria is required to induce pneumococcal meningitis and this threshold varies depending upon the route of infection. 6 The present study examines whether the presence of a cochlear implant alters the threshold of bacteria required for meningitis.
MATERIALS AND METHODS

Source of the Animals
All the experimental animals were bred and housed in the animal house within the Department of Otolaryngology, University of Melbourne. All procedures and animal handling were conducted in accordance with guidelines set by the Animal Research and Ethics Committee of the Royal Victorian Eye and Ear Hospital and The Australian Code of Practice for the Care and Use of Animals for Scientific Purposes from the National Health and Medical Research Council (2004) .
In total, 54 otologically normal, adult Hooded-Wistar rats (10-16 weeks old, weight 100-450 g) were used in the study. One cohort of 18 rats underwent a cochlear implantation on the left ear 4 weeks prior to inoculation with bacteria. The second control cohort of 18 animals had a cochleostomy 4 weeks prior to inoculation. The third cohort of 18 (surgical insertion of implant only) had a cochleostomy, followed by insertion and immediate removal of the cochlear implant 4 weeks prior to inoculation. The third cohort was designed to investigate if standard electrode array insertion technique, which might induce a certain degree of inner cochlear trauma, altered the risk of CNS infection.
Eighteen rats were allocated to each of the three different routes of bacterial inoculation (middle ear, inner ear, and intraperitoneal [IP]; Table 1 ). The S. pneumoniae count for each route of inoculation was chosen based on a previously established threshold model to ensure a subthreshold level of infection in healthy rats with a cochleostomy. 6
Surgical Anesthesia
Anesthesia and postoperative care have been described in detail previously. 5, 6 In brief, rats were anesthetized with an IP injection of a mixture of 8 mg/kg xylazine (Ilium Xylazil-20; Troy Laboratories Pty Ltd, New South Wales, Australia) and 75 mg/kg ketamine hydrochloride (Ketamine; Parnell Laboratories, New South Wales, Australia). A local anesthetic agent (0.1 mL of lignocaine hydrochloride with 0.0182 mg/mL adrenaline tartrate; Troy Laboratories) was injected subcutaneously (SC) around the surgical incision. The animals were given 0.03-0.05 mg/kg SC buprenorphine (Temgesic; Reckitt Benckiser, New South Wales, Australia) for analgesia immediately after surgery.
Animal Surgery
Scala tympani electrode array design and cochlear implant surgery. The dummy scala tympani electrode 5 consisted of 5 mm of polyimide tubing (Cole-Parmer Instrument Co, Vernon Hills, IL) with an outer diameter of 0.10 mm, coated with a layer of silicone (Medical Grade Elastomer MDX4-4210; Factor II, Lakeside, AZ) to a diameter of 0.15 mm. The dummy electrodes were cleaned with absolute alcohol in an ultrasonic cleaner, rinsed with Milli-Q (Millipore, Billerica, MA) water three times, and then bathed in Milli-Q water for 10 minutes before drying, packaging, and sterilizing using H 2 O 2 sterilization (STERRAD 100S; Advanced Sterilization Products, Johnson & Johnson, Irvine, CA).
Eighteen adult Hooded-Wistar rats were implanted in the left cochlea with a dummy electrode. Using sterile techniques, a postauricular skin incision was made to expose the bulla, which was opened up to expose the round window niche (RWN). The bulla cavity was inspected for any abnormality of the middle ear mucosa. The stapedial artery, which is located just below the RWN, was cauterized. A cochleostomy (approximately 0.2 mm in diameter) was made just below the RWN and at the location of the previously cauterized stapedial artery. 5, 7 The dummy electrode The number of animals used and the size of the inoculum for each route were based on previous work. The bacterial counts for each inoculation route has shown not to induce meningitis in three groups of six healthy rats with cochleotomy over 5 days of monitored infection period. 6 was inserted 2-3 mm into the scala tympani via the cochleostomy, which was sealed with temporalis fascia. The extracochlear portion of the implant remained within the bulla cavity after the insertion.
Surgical procedures to control rats. Eighteen adult rats underwent a cochleostomy to the left ear as described above.
No electrode was inserted into the inner ear. The cochleostomy site was covered with temporalis fascia.
Surgical procedures to rats with acute scala tympani electrode insertion. Eighteen adult rats underwent a cochleostomy to the left ear. A dummy scala tympani electrode was inserted into the inner ear via the cochleostomy and then removed. The cochleostomy site was covered with temporalis fascia.
All animals were administered two doses of prophylactic antibiotics: enrofloxacin (Baytril 50; Bayer Australia Ltd, New South Wales, Australia) 10 mg/kg SC diluted 1:1 with saline. One dose was given immediately after surgery, and the second dose was given 12 hours later.
Inoculation of S. pneumoniae
Four weeks after surgery, all animals were inoculated with S. pneumoniae 447A, which carries type 2 capsular antigen and was selected for the study based on our previous experience with this specific serotype in a feline otitis media model 8, 9 and a rat meningitis model. 5, 6 This organism was a clinical isolate from the CSF of a child who had been diagnosed with meningitis. The detailed preparation of the bacterial inocula has been described in our previous studies. 5, 6 The number of bacteria for each route of inoculation is given in Table 1 and was derived from the previously established threshold model. 6 Retrospective viable counts of the inoculum confirmed that each rat received the desired amount of bacteria.
Three methods of bacterial inoculation (IP, middle ear, and inner ear) were carried out to study the effect of different routes of infection on the risk of meningitis in rats implanted with a dummy electrode and in rats with acute electrode insertion alone. Bacteremia, as a result of IP inoculation, was introduced to study hematogenous spread of infection without the possible confounding effect of direct invasion of the meninges from the middle ear infection. The direct inoculation of the bacteria into the inner ear was introduced to study direct route of infection from the middle ear to the meninges via inner ear without the bacteremia that may accompany middle ear infection. Note that no antibiotics were given after S. pneumoniae infection.
Intraperitoneal Inoculation
Eighteen rats (six from each cohort) were anesthetized using a mixture of isoflurane and oxygen and 4 ϫ 10 6 colonyforming units (CFU) of the bacteria in 1 mL of phosphatebuffered saline was directly injected into the peritoneal cavity using a sterile 20-gauge needle and 1-mL syringe.
Middle Ear Inoculation
Under general anesthesia, the left bulla of 18 rats (six from each cohort) was surgically exposed and inoculated with 3 ϫ 10 4 CFU in 10 L of phosphate-buffered saline. To retain the microorganisms in the bulla, the cavity was first filled with Gelfoam (Pharmacia & Upjohn, Kalamazoo, MI). After the inoculation of the bacteria, the opening of the bulla was covered with temporalis fascia, and the wound was sutured in two layers.
Inner Ear Inoculation
Under general anesthesia, the left bulla of 18 rats (six from each cohort) was surgically exposed and a cochleostomy next to the previous surgical site to access the scala tympani was performed with a straight Kirschner wire. Two microliters of perilymph fluid was removed, and 1 L of bacterial inoculum containing 1 ϫ 10 3 CFU was inoculated into the scala tympani over 1 minute using an infusion catheter, 5-L microsyringe (ILS, Stützerbach, Germany), and a microsyringe pump controller (World Precision Instruments Inc., Sarasota, FL) ( Table 1 ). After inoculation, the cochleostomy was covered with temporalis fascia. The opening of the bulla was also covered with temporalis fascia, and the wound was sutured in two layers.
Postinfection Monitoring
Following the inoculation, each animal was examined, at minimum, twice daily for clinical signs of meningitis over 5 days. A clinical assessment was recorded in a 12-point scored monitoring sheet. 5 Animals were killed if one of the following conditions was met: a score of 10 or above; a weight loss of greater than 25%; or a score of 5-10 with rectal temperature of greater than 41°C. Animals without clinical evidence of meningitis were killed at the end of the fifth day.
Microbiological Specimen Collection and Tissue Preparation
The outcome of the study was to detect the presence of meningitis. The meninges and brains were harvested for histologic analysis and were used to confirm the diagnosis of meningitis. CSF, blood culture, and middle ear cultures were collected as adjunct to the brain histology for the detection of bacteria to ensure that the strain causing the disease was the same as that used for the inoculum.
Once the rats developed early signs of meningitis (see later), isoflurane and oxygen were used to deeply anesthetize them, allowing collection of CSF, middle ear fluid, and blood for microscopy and culture. 5, 6 The method of specimen collection has been described previously. [10] [11] [12] [13] [14] After specimen collection, the animals were given a lethal dose of pentobarbitone sodium (120 mg/kg intramuscularly, Lethabarb; Virbac Pty Ltd, New South Wales, Australia) and were transcardially perfused with 0.9% saline and then 10% neutral buffered formalin (NBF) (pH 7.4) at 4°C. The brain, meninges, and cochleae were harvested and placed in 10% NBF for further processing.
All 54 brains with meninges were harvested, stored in 10% NBF for 48 hours, and then embedded in paraffin. The specimens were sectioned 10 m thick, stained with both hematoxylin and eosin (H&E) and Gram stain, and examined under light microscopy for presence of inflammation and Gram-positive cocci. The reviewers of the histologic brain specimen were blinded to the experimental groups.
Nine pairs of randomly selected cochleae were harvested from the temporal bones and fixed in 10% NBF. They were decalcified in a solution of 10% ethylenediaminetetraacetic acid (EDTA) in 0.1 M phosphate buffer (pH 7.4) and oriented in the midmodiolar position and then embedded in Spurr's resin. Two sets of 21 sections of 2 m were collected at 126-m intervals throughout the cochlea. One set of 21 sections was stained with H&E, and the other set was stained with Gram stain.
Histologic Analysis
The sections of histologic specimens were examined under a light microscope. The brain and meninges were examined for the presence of inflammatory cells within the subarachnoid space and brain tissue, thickening and hyperplasia of the meningeal cells, and Gram-positive cocci within the subarachnoid space and brain tissue. The cochleae were examined for the presence of bacteria and inflammatory cells.
Statistical Analysis
The effects of cochlear implantation and standard surgical insertion technique on the threshold of infection for the three different routes of inoculation were evaluated statistically using Fisher's exact test (one-tailed). 6
RESULTS
When rats developed signs of meningitis, they appeared lethargic, were unresponsive to stimulation by sound or light, had a hunched posture, and exhibited poor grooming, weight loss, and a rectal temperature above 38°C. When these signs developed, CNS histology consistently showed evidence of meningitis with inflammatory cells and Grampositive diplococci within the subarachnoid space. The correlation between the clinical signs of meningitis and the histopathologic evidence of meningitis was established in our previous work. 5, 6 Eighteen rats with the cochlear implant developed both clinical and histologic evidence of meningitis regardless of the route of inoculation. There was some variation in the time required for the implanted rats to develop meningitis. Three of six IP inoculated rats developed meningitis within 32 hours, whereas the other three in this group showed signs of meningitis after approximately 102-120 hours. Three of the implanted rats with middle ear inoculation developed meningitis within 48-52 hours, and the other three implanted rats inoculated via this route developed meningitis around 96-120 hours after inoculation. Likewise, three of the implanted rats with inner ear inoculation developed meningitis within 50 hours, whereas the other three rats developed meningitis at 96-102 hours. In contrast, none of the 18 rats with cochleostomy-only (control cohort) developed meningitis when inoculated with the same number of bacteria. The effect of cochlear implantation on the attack rate of meningitis was statistically significant (P ϭ 0.001 Fisher exact test, one-tailed; Table 2 ).
Two of the 18 rats that had undergone acute electrode insertion only developed meningitis when the bacteria were inoculated into the middle ear cavity. Both rats developed meningitis 110-112 hours postinoculation. The effect of acute insertion of the implant on the attack rate of meningitis was not statistically significant (P Ͼ 0.2 for middle ear, inner ear, and IP inoculation; Table 2 ).
Microbiology
The results of bacterial cultures of CSF, blood, and middle ear swabs are summarized in Table 3 . Typing of bacteria isolated from the rats showed them to be the same serotype as the inoculum.
Cochlear Histology
The pattern and distribution of bacteria and inflammatory cells within the cochleae of rats with clinical and histologic evidence of meningitis were consistent with our previous studies. 5, 6 In brief, the amount and distribution of inflammatory cells were symmetrical in both cochleae of rats with an IP inoculation. However, the inflammatory changes within the cochleae were asymmetrical in meningitic animals following middle and inner ear inoculations. In these cases, a more severe labyrinthitis was observed in the cochlea ipsilateral to the inoculation. Inflammatory cells and bacteria were also found to infiltrate the fibrous connective tissue seal surrounding the intracochlear portion of the dummy electrode array in rats receiving middle and inner ear inoculations (Fig 1) . In rats without meningitis, the histologic appearance of the cochleae was normal for IP and middle ear inoculations; rats receiving inner ear inoculation typically exhibited small numbers of inflammatory cells and serofibrinous exudate in the basal turn of the cochleae.
Microscopic examination of the ipsilateral middle ear mucosa of the RWN revealed evidence of middle ear inflammation in rats with direct middle ear inoculation. The contralateral control bullae showed no evidence of middle ear inflammation. There was no microscopic evidence of inflammatory changes within the middle ear mucosa of rats with IP or direct inner ear inoculation.
DISCUSSION
This study demonstrates, for the first time, that the presence of a cochlear implant in healthy rats reduces the infectious threshold. The amount of bacteria required to induce pneumococcal meningitis, for all three routes of inoculation-1) general hematogenous route via IP inoculation, 2) inoculation of the middle ear, and 3) direct inoculation of the cochlea-was significantly reduced in the presence of a cochlear implant. Our previous work has illustrated that a minimal infectious threshold is required to induce pneumo-coccal meningitis in healthy rats and the threshold is different for the three different routes of infection. 6 Moreover, a cochleostomy without cochlear implantation did not alter the threshold level of infection, 6 and this result was reconfirmed in this present study. All the animals (both the control and the interventional groups) were infected with subinfectious threshold of inocula 4 weeks after the initial surgical interventions. It is important to stress that, during cochlear implantation, there are two key surgical steps that might influence the infectious threshold: the cochleostomy and the actual insertion of electrode array. To study the effects of implantation on the infection threshold, it is important to have two control groups for comparison. Therefore, one control group of animals received a cochleostomy alone, while the other group received a cochleostomy followed by acute insertion of a dummy electrode array (ie, the array was immediately withdrawn). There was no clear evidence of meningitis when subthreshold quantities of bacteria were inoculated into rats that had a cochleostomy or acute insertion of a dummy electrode array. However, with the same bacterial counts, all 18 implanted rats acquired meningitis via the three different routes of inoculation. The significance of this finding is that the presence of a foreign body, such as the cochlear implant, can be considered as an independent risk factor for pneumococcal meningitis.
It is important to emphasize that rodents have a wider cochlear aqueduct than do humans, and this may increase their risk of meningitis. However, both the control groups and the implanted groups are from animals of the same species and age. Therefore, the size of the cochlear aqueduct is similar in all groups. As the infectious threshold was reduced in the implanted group, we can conclude that it was the implant per se, and not the patent cochlear aqueduct, that caused the reduction in the infectious threshold. Therefore, this possible confounder was not an issue for interpretation of the results. If we want to study the effects of the cochlear aqueduct on the infectious threshold, then a different experimental design is needed. In this instance, one group of animals with a wide and patent cochlear aqueduct would be compared to a group with a smaller, narrower aqueduct.
The exact mechanism(s) of how cochlear implants contribute to the risk of acquiring meningitis are unclear based on previous clinical data. [2] [3] [4] However, this study illustrates that one of the possible mechanisms is by reducing the infectious threshold of bacteria required to induce meningitis. The presence of a foreign body, such as a cochlea implant, may reduce the ability of the rats' immune system to fight pneumococcal infection. Therefore, fewer bacteria are required to overwhelm the immune system compared to nonimplanted rats. Previous studies have illustrated that the presence of a rigid, perforated, polytetrafluoroethylene tube in the subcutaneous tissue of animals increased the apoptotic activity of polymorphonuclear leukocytes and impaired their ability to phagocytose bacteria. [15] [16] [17] It is likely that a foreign body in the inner ear can also reduce the ability of the immune cells to eliminate S. pneumoniae, although the detailed molecular mechanism(s) of how the foreign body impairs the function of immune cells remains unknown. However, with an impaired local immunity around the implant, a lesser quantity of bacteria was required to induce meningitis in the implanted rats. Therefore, the threshold of pneumococcal infection has been lowered in the presence of a foreign body, probably as a result of an enhanced capacity of the bacteria to proliferate around the implant. Similarly, in a study that involved the injection of Staphylococcus aureus subcutaneously into sites with and without implanted foreign bodies, significantly smaller numbers of bacteria were required to induce infection in the presence of tissue cages. 16 In that particular study, an infection rate of 100% was observed in the implant site following the inoculation of 1 ϫ 10 3 CFU of S. aureus. However, in the absence of a subcutaneous foreign body, an inoculation of 1 ϫ 10 8 CFU of S. aureus did not induce skin infection. 16 Even though this study used a different bacterium, a different type of foreign body, and a different implant location, the findings are consistent with our work. However, it is important to stress that the mechanism increasing the risk of infection may not be immunologic. The presence of a foreign body may physically interfere with the formation of a fibrous seal around the cochleostomy site, although our histologic findings did not suggest this hypothesis.
Our previous work demonstrated that rats cleared all infection from their system 5 days after inoculation if they did not develop meningitis. 5, 6 It is important to stress that shortening the time required for meningitis development can be an adjunct outcome measure to indicate a threshold alteration. Although it is not directly measuring the threshold, it suggests that the intervention increases the risk of meningitis by shortening the time required for meningitis. This finding by itself may have important clinical implications. In essence, clinicians may need to treat implanted patients early as they may develop meningitis sooner in the event of upper respiratory tract infection.
The possible mechanism(s) of pneumococcal meningitis in implanted patients can be further explored by examining the effects of cochlear implantation on the routes by which S. pneumoniae reach the meninges. In the presence of a cochlear implant, the otogenic route of spread of infection (infection spread from middle ear to the inner ear and then to the meninges) has been considered to be the main pathway for postimplantation meningitis. 18, 19 However, our work has demonstrated that both hematogenous and direct otogenic routes of infection can induce meningitis in implanted rats. 5 Furthermore, only 40% of subjects with postimplantation meningitis were found to have concurrent acute otitis media. 3 Therefore, there may be differences in the pathogenesis of pneumococcal meningitis among subjects with a cochlear implant depending upon the route of bacterial infection. The presence of the implant may reduce the local inner ear immunity and allow a direct invasion of CNS when bacteria are inoculated into the middle or the inner ear. On the other hand, the implant can also reduce the global CNS immunity to allow bacterial invasion of the blood-brain barrier from the systemic circulation.
The significance of hematogenous spread of infection, from the upper respiratory tract mucosa to the meninges, in precipitating meningitis in implanted humans is unclear. However, the present study demonstrates that implanted rats were at risk of pneumococcal meningitis when the bacteria were introduced intraperitoneally. The exact mechanism of how the presence of an implant can alter the threshold of bacteria via a hematogenous route remains unclear. It is possible that the bacteria seeded around the implant from the systemic circulation and then moved to the CNS from the inner ear. However, the histology of cochleae of implanted rats with meningitis did not show any evidence of seeding of the bacteria within the scala tympani around the implanted site. This may be due to the removal of bacteria from the cochlea when the implant was removed during histologic processing. If this is true, one would expect to see a more severe degree of labyrinthitis in the implanted cochlea compared to the contralateral site. Interestingly, the severity of labyrinthitis was similar when comparing implanted to nonimplanted cochleae following IP inoculation; the bacteria were predominantly located in the internal acoustic meatus and modiolus in both cochleae. This observation is consistent with our previous work 5 and implies that the presence of a foreign body in the inner ear reduces the global immune surveillance of the CNS, allowing bacteria in the circulation to invade the blood-brain barrier. A previous study in an animal model showed that any breach of the dura reduces the threshold of bacteremia required to produce meningitis. 20 This suggests that any direct or indirect injury to the dura may reduce CNS immunity and result in a reduction in the number of bacteria required to induce meningitis. Due to the close anatomical relationship of the inner ear to the CNS, the presence of an implant in the inner ear may also reduce the overall immune defense of the CNS in a way that is not clear. Interestingly, as demonstrated in our previous work, 6 the presence of a cochleostomy in the inner ear did not alter the threshold for meningitis via the hematogenous route. The local breach of the bony capsule of the basal turn (cochleostomy) did not appear to affect the integrity of the global immune surveillance of the CNS. This further strengthens the notion that it was the presence of the foreign body in the inner ear and not the cochleostomy per se that reduced the threshold for meningitis via the hematogenous route.
Inner ear trauma as a result of cochlear implantation has been considered to be a possible risk factor for postimplantation meningitis. 18 Our earlier study suggested that trauma to the osseous spiral lamina of the basal turn may provide easier access for the bacteria to access perineural and perivascular spaces within the modiolus and the internal acoustic meatus. 5 However, in the present study, the standard surgical insertion technique for cochlear implantation in healthy rats did not shift the threshold required for infection. Moreover, minimal or no trauma to the bony and membranous labyrinth was observed in the cochleae of rats that received acute insertion of an electrode array, further strengthening the notion that a cochlear implant is an independent risk factor for postimplantation pneumococcal meningitis.
The histologic appearance of the cochleae in implanted rats with meningitis was consistent with our previous study and dependent on the route of infection. 5 A symmetrical distribution of Gram-positive bacteria and inflammatory cells within the internal acoustic meatus and modiolus was found in both cochleae of rats with IP inoculation. Although few isolated bacteria were seen within the stria vascularis, no bacteria or inflammatory cells were seen within the scala tympani and vestibuli and there was no evidence to suggest that bacteria traversed blood vessels to enter the scala media. An asymmetrical distribution of the bacteria and inflammatory cells was seen in meningitic rats with both middle and inner ear inoculations: the labyrinthitis of the ipsilateral inoculated ear, involving all three scalae, was more extensive than that observed in the contralateral cochlea. The difference in the severity of labyrinthitis between the ipsilateral and the contralateral cochlea, viewed in the context of a reduced threshold for CNS infection, suggested a reduction of the inner ear immunity at the local level due to the presence of the dummy electrode array. In rats with middle ear infection and meningitis, bacteria infiltrated the fibrous tissue seal around the implant to reach the scala tympani. This also provides support for the notion that meningitis might have been caused by direct spread of infection from the middle ear into scala tympani and then to the CNS. As bacteremia was also identified in these rats, however, it is difficult to completely exclude the possibility of hematogenous spread to the meninges following middle ear infection. However, one would have expected a more symmetrical distribution of the bacteria and inflammatory cells within their cochleae if this was the dominant route.
Although the benefits of cochlear implants in human subjects far outweigh the small risk of meningitis postcochlear implantation, every effort should be made to ensure long-term patient safety. Acute otitis media has been diagnosed concurrently with meningitis in some implanted patients. If there is a reduction in the threshold of bacteria required to induce meningitis in implanted recipients, as suggested by this animal study, then aggressive antibiotic treatment of patients with acute otitis media is necessary to prevent subsequent meningitis. Furthermore, the presence of a cochlear implant can reduce the threshold of bacteremia required for subsequent pneumococcal meningitis. Therefore, in implanted subjects with febrile illness of unknown focus and possible pneumococcal bacteremia, full microbiological investigation and early treatment with broad-spectrum antibiotics would be advisable. Pneumococcal vaccination is also highly recommended for all future and current cochlear implant recipients to reduce the risk of meningitis following pneumococcal infection. 2 The animal model established in this study can also be used to examine the effectiveness of pneumococcal vaccination, to improve the prosthesis design and/or modify surgical procedure in order to raise the threshold of bacteria required to cause meningitis.
The findings from the present study also have a wider implication than cochlear implant surgery and pneumococcal infection. The presence of a foreign body in the CNS, such as a CSF shunt, has been shown to increase the risk of meningitis, 2 and this is likely to be related to the reduction of the threshold of bacteria required to cause meningitis. It is also possible that any surgical intervention associated with a breach of the dura can reduce the threshold of bacteria required to produce meningitis. The model described in this study can be further developed or modified to examine the effects of other neurosurgical prostheses or neurosurgical interventions on the subsequent risk of bacterial meningitis.
CONCLUSION
The cochlear implant increases the risk of pneumococcal meningitis in healthy rats by reducing the threshold of bacteria required to cause the disease. The threshold of infection is reduced for all potential routes of spread of infection, including the bloodstream, the upper respiratory tract, and the inner ear to the meninges. Early diagnosis and treatment of otitis media and systemic febrile illness may reduce the risk of pneumococcal meningitis in cochlear-implanted recipients by preventing bacterial counts from reaching the threshold required for infection. Pneumococcal vaccination is also highly recommended for all future and current cochlear implant recipients to reduce the risk of meningitis. There is no evidence to suggest that the standard surgical insertion technique of cochlear implantation increases the risk of pneumococcal meningitis.
